Identifying Novel Pathways to Tackle the Proinflammatory Potential of Mesenchymal Stem Cells from Multiple Sclerosis Patients (P6-1.003)
To identify targets for mitigating the proinflammatory potential of mesenchymal stem cells (MSC) from people with multiple sclerosis (MS), which can be used to improve the immunomodulatory abilities of MSC in clinical autologous treatment interventions.
Authors
- Louise C. Showe (ORCID: https://orcid.org/0000-0002-7818-4220)
- P.D.S.U. Wickramasinghe
- Nanci Frakich
- Andrew V. Kossenkov (ORCID: https://orcid.org/0000-0002-1536-0418)
- Bruno Gran (ORCID: https://orcid.org/0000-0001-6384-2342)
- Sergio L. Colombo (ORCID: https://orcid.org/0000-0001-7360-986X)
- Sarah Thevathas
- Rhodri E. Jones
- Kiranmai Gumireddy
- Cris S. Constantinescu (ORCID: https://orcid.org/0000-0003-2066-7585)
- David Onion (ORCID: https://orcid.org/0000-0002-4522-2307)
- Ian Spendlove (ORCID: https://orcid.org/0000-0002-7480-3768)
- Sonali Majumdar (ORCID: https://orcid.org/0000-0002-6574-8787)
- Radu Tanasescu
- Cherry Chang
Institutions
- The Wistar Institute (US)
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Nottingham Trent University (GB)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208571
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00